BRIEF published on 07/10/2024 at 07:35, 2 years 2 months ago Evotec and Pfizer Collaborate to Advance Drug Discovery in France Drug Discovery Metabolic Diseases Evotec Pfizer Infectious Diseases
BRIEF published on 07/10/2024 at 07:35, 2 years 2 months ago Evotec et Pfizer collaborent pour faire progresser la découverte de médicaments en France Maladies Métaboliques Evotec Découverte De Médicament Pfizer Maladies Infectieuses
PRESS RELEASE published on 07/10/2024 at 07:30, 2 years 2 months ago Evotec and Pfizer collaborate to advance drug discovery in France Evotec SE collaborates with Pfizer to focus on early discovery research for metabolic and infectious diseases in France. The multi-year agreement includes research support and potential milestones Drug Discovery Evotec SE France Pfizer Metabolic And Infectious Diseases
BRIEF published on 07/08/2024 at 14:05, 2 years 2 months ago Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz Partnership Biosimilars Evotec Sandoz Biologics
BRIEF published on 07/08/2024 at 14:05, 2 years 2 months ago Just – Evotec Biologics étend son partenariat technologique pour les biosimilaires avec Sandoz Partenariat Evotec Biosimilaires Produits Biologiques Sandoz
PRESS RELEASE published on 07/08/2024 at 14:00, 2 years 2 months ago Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz Evotec SE's biologics segment, Just - Evotec Biologics, expands partnership for biosimilars with Sandoz, securing long-term commercial supply. Collaboration aims for cost-efficient development Evotec SE Biosimilars Just - Evotec Biologics Sandoz Commercial Supply
BRIEF published on 06/25/2024 at 07:35, 2 years 3 months ago Just-Evotec Biologics Selected by U.S. DOD for Manufacturing Optimization Evotec SE Biologics Manufacturing U.S. Department Of Defense Monoclonal Antibodies Medical Countermeasures
BRIEF published on 06/25/2024 at 07:35, 2 years 3 months ago Just-Evotec Biologics sélectionné par le DOD américain pour l'optimisation de la fabrication Evotec SE Fabrication De Produits Biologiques Département Américain De La Défense Des Anticorps Monoclonaux Contre-mesures Médicales
PRESS RELEASE published on 06/25/2024 at 07:30, 2 years 3 months ago Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program Just \/ Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program. Evotec SE subsidiary chosen for $39m accelerated mAb development project Evotec SE Just - Evotec Biologics U.S. Department Of Defense Manufacturing Optimization Program MAb Development
BRIEF published on 06/12/2024 at 07:35, 2 years 3 months ago Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb Collaboration Neuroscience Evotec Neurodegenerative Diseases Bristol Myers Squibb
Published on 10/03/2026 at 02:35, 14 hours 39 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 3 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 4 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 4 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 1 hour 29 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 17 hours 19 minutes ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 20 hours 50 minutes ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 21 hours 28 minutes ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 22 hours 14 minutes ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 17:45, 23 hours 29 minutes ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 23 hours 29 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 23 hours 39 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 23 hours 44 minutes ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 23 hours 44 minutes ago Aéroports de Paris SA - Calendrier financier 2027
